Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma, Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT02965716
What this trial is testing

Talimogene Laherparepvec and Pembrolizumab in Treating Patients With Stage III-IV Melanoma

Who this might be right for
Advanced MelanomaRecurrent MelanomaStage III Cutaneous Melanoma AJCC v7+5 more
National Cancer Institute (NCI) 43
Not applicableUnknownNCT04799106
What this trial is testing

Community Based Strategies for Early Detection of Melanoma

Who this might be right for
Melanoma
Cedars-Sinai Medical Center 200
Testing effectiveness (Phase 2)Study completedNCT03618641
What this trial is testing

CMP-001 in Combo With Nivolumab in Stage IIIB/C/D Melanoma Patients With Clinically Apparent Lymph Node Disease

Who this might be right for
MelanomaLymph Node Cancer
Diwakar Davar 34
Testing effectiveness (Phase 2)Study completedNCT00002973
What this trial is testing

Melphalan and Whole-Body Hyperthermia in Treating Patients With Advanced Melanoma

Who this might be right for
Melanoma (Skin)
University of Wisconsin, Madison 34
Not applicableStudy completedNCT00026754
What this trial is testing

Eligibility Screening for the NIH Intramural Research Program Clinical Protocols

Who this might be right for
Breast CancerProstate CancerLung Cancer+2 more
National Cancer Institute (NCI) 19,522
Not applicableStudy completedNCT02133222
What this trial is testing

Circulating Cell-free DNA in Metastatic Melanoma Patient: Mutational Analyses in Consecutive Measurement Before and After Chemotherapy

Who this might be right for
Metastatic (Stage IV) Melanoma
Centre Hospitalier Universitaire de Nice 22
Early research (Phase 1)Study completedNCT01127594
What this trial is testing

Evaluate Safety/Tolerability Intra-Arterial Temozolomide in Patients w/Extremity Melanoma by Isolated Limb Infusion

Who this might be right for
Melanoma
Douglas Tyler 29
Early research (Phase 1)Looking for participantsNCT07027488
What this trial is testing

AB821 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Melanoma and Normal or ImpairedAdvanced Melanoma
Yale University 50
Not applicableStudy completedNCT03771859
What this trial is testing

Patients Receiving Adjuvant Nivolumab Therapy for Melanoma That Has Been Removed

Who this might be right for
Melanoma
Bristol-Myers Squibb 152
Testing effectiveness (Phase 2)Study completedNCT00002786
What this trial is testing

Biological Therapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Fred Hutchinson Cancer Center 20
Not applicableEnded earlyNCT04899492
What this trial is testing

Evaluating Smoking Cessation Protocols in Cancer Patients: NRT, MI, CBT or Hypnotherapy

Who this might be right for
Breast CancerGynecologic CancerDigestive Cancer+1 more
Institut Cancerologie de l'Ouest 21
Not applicableStudy completedNCT05740501
What this trial is testing

Pharmacokinetic Profiling of Pembrolizumab and Nivolumab in Patients With Melanoma and/or Non-Small Cell Lung Cancer

Who this might be right for
Lung Non-Small Cell CarcinomaMelanoma
Mayo Clinic 13
Testing effectiveness (Phase 2)Ended earlyNCT00358319
What this trial is testing

Phase I/II Trial of Valproic Acid and Karenitecin for Melanoma

Who this might be right for
Malignant Melanoma
H. Lee Moffitt Cancer Center and Research Institute 42
Not applicableStudy completedNCT06369428
What this trial is testing

Patient Characteristics, Treatment Patterns, and Healthcare Resource Utilization of Metastatic Melanoma Patients

Who this might be right for
Metastatic Melanoma
Novartis 1,795
Not applicableLooking for participantsNCT07760012
What this trial is testing

68Ga-SorB PET/CT Imaging in Patients With Solid Tumors

Who this might be right for
Melanoma (Skin Cancer)Hepatocellular CarcinomaLung Cancer+3 more
Peking University Third Hospital 50
Not applicableActive Not RecruitingNCT03941379
What this trial is testing

A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma

Who this might be right for
Choroidal MelanomaIndeterminate Lesions of Eye
Aura Biosciences 63
Large-scale testing (Phase 3)Looking for participantsNCT07015190
What this trial is testing

Neoadjuvant Darovasertib in Primary Uveal Melanoma

Who this might be right for
Uveal Melanoma
IDEAYA Biosciences 520
Testing effectiveness (Phase 2)UnknownNCT04884997
What this trial is testing

Toripalimab or Combining With Temozolomide（iv） in the Treatment of Advanced/Metastatic Malignant Melanoma

Who this might be right for
Malignant Melanoma
First Affiliated Hospital of Zhejiang University 90
Testing effectiveness (Phase 2)WithdrawnNCT05561491
What this trial is testing

ONCOS-102 in Combination With Other Novel Immune-therapies in Advanced Treatment-resistant Melanoma Patients

Who this might be right for
Melanoma
Targovax Oy
Testing effectiveness (Phase 2)UnknownNCT05106023
What this trial is testing

To Explore the Efficacy and Safety of SHR-1701 Combined With Temozolomide in the Treatment of Advanced Melanoma

Who this might be right for
Melanoma
Yong Chen 31
Next Page